Individual Patient Data Meta-analysis of Drug-eluting Versus Bare-metal Stents for Percutaneous Coronary Intervention in Chronic Versus Acute Coronary Syndromes

Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA

(2022) Daniel B. Mark et al.   CIRCULATION

Initial Invasive or Conservative Strategy for Stable Coronary Disease

(2020) David J. Maron et al.   NEW ENGLAND JOURNAL OF MEDICINE

Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction

(2019) Lorenz Räber et al.   EUROPEAN HEART JOURNAL

Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials

(2019) Raffaele Piccolo et al.   LANCET

The myth of ‘stable’ coronary artery disease

(2019) Keith A. A. Fox et al.   Nature Reviews Cardiology

Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention

(2018) Tullio Palmerini et al.   JACC-Cardiovascular Interventions

Five-Year Outcomes with PCI Guided by Fractional Flow Reserve

(2018) Panagiotis Xaplanteris et al.   NEW ENGLAND JOURNAL OF MEDICINE

2018 ESC/EACTS Guidelines on myocardial revascularization

(2018) Franz-Josef Neumann et al.   EUROPEAN HEART JOURNAL

From bare metal to barely anything: an update on coronary stenting

(2017) Raffaele Piccolo et al.   HEART

Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy

(2017) Raffaele Piccolo et al.   JACC-Cardiovascular Interventions

Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?

(2017) David J Fisher et al.   BMJ-British Medical Journal

Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?

(2017) David J Fisher et al.   BMJ-British Medical Journal

Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non–ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction

(2016) Thomas Pilgrim et al.   AMERICAN HEART JOURNAL

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial

(2016) Manel Sabaté et al.   LANCET

Stable coronary artery disease: revascularisation and invasive strategies

(2015) Raffaele Piccolo et al.   LANCET

Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting

(2014) Salvatore Cassese et al.   EUROPEAN HEART JOURNAL

Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis

(2014) M. Valgimigli et al.   BMJ-British Medical Journal

Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis

(2014) S. Windecker et al.   BMJ-British Medical Journal

When Stable Becomes Unstable

(2011) Nihar R. Desai et al.   CIRCULATION

Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy

(2011) G.B. John Mancini et al.   Circulation-Cardiovascular Interventions

Effect of PCI on Quality of Life in Patients with Stable Coronary Disease

(2008) William S. Weintraub et al.   NEW ENGLAND JOURNAL OF MEDICINE